NanoViricides, Inc. (NNVC) recently purchased by insider Boniuk Milton

NanoViricides, Inc. (NYSE:NNVC) marched up 7.19% compared to a 52-week low price of $0.83. The shares were last seen trading -5.33% lower, taking the closing price at $0.89 on 02/13/2018. At recent session, the prices were hovering between $0.89 and $0.95. This company shares are 495.51% off its target price of $5.3 and the current market capitalization stands at $57.52M. The recent change has given its price a -8.34% deficit over SMA 50 and -45.73% deficit over its 52-week high. The stock witnessed -1.11% declines, -11% declines and -32.58% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found NNVC’s volatility during a week at 6.61% and during a month it has been found around 8.37%.

NanoViricides, Inc. (NNVC) Top Holders

Institutional investors currently hold around $4 million or 6% in NNVC stock. Look at its top three institutional owners. Vanguard Group Inc owns $1.05 million in NanoViricides, Inc., which represents roughly 1.82% of the company’s market cap and approximately 26.13% of the institutional ownership. Similar statistics are true for the second largest owner, Renaissance Technologies Llc, which owns 485,000 shares of the stock are valued at $456 thousand. The third largest holder is Cowen Inc., which currently holds $351 thousand worth of this stock and that ownership represents nearly 0.61% of its market capitalization.

NanoViricides, Inc. 13F Filings

At the end of 09/30/2017 reporting period, 16 institutional holders increased their position in NanoViricides, Inc. (NYSE:NNVC) by some 235,413 shares, 8 decreased positions by 67,574 and 24 held positions by 3,490,360. That puts total institutional holdings at 3,793,347 shares, according to SEC filings. The stock grabbed 7 new institutional investments totaling 118,819 shares while 1 institutional investors sold out their entire positions totaling 11,409 shares.

NanoViricides, Inc. (NYSE:NNVC) Insider Trades

Multiple company employees have indulged in significant insider trading. NanoViricides, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Boniuk Milton has acquired 25,000 shares of NanoViricides, Inc. (NNVC) in trading session dated Nov. 11, 2015. These shares are worth $30,000 and were traded at $1.2 each. The SEC filing shows that Boniuk Milton performed a purchase of 25,000 shares. The Director added these shares by way of transaction on Oct. 22, 2015. The company’s shares were assimilated at $1.3 per share worth to an investment of some $32,500 on account of Boniuk Milton.

Director, Boniuk Milton, purchased 50,000 common shares of NanoViricides, Inc. (NNVC) in the open market. In a transaction dated Sep. 11, 2015, the shares were bought at an average price of $1.02, giving away a sum of $51,000. After this purchase, 100,000 common shares of NNVC are directly owned by the insider, with total stake valued at $89,000.

In the transaction dated Aug. 26, 2015, the great number of shares acquired came courtesy the Director; Boniuk Milton added a total of 50,000 shares at an average price of $1.05, amounting to approximately $52,500. The insider now directly owns 1,705,391 shares worth $1,517,798.

Previous article25 hedge funds buy J.Jill, Inc. (JILL) for the first time
Next articleDimensional Fund Advisors Lp is the biggest holder of Werner Enterprises, Inc. (WERN)